Nucliq Biologics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $339K

  • Investors
  • 8

Nucliq Biologics General Information

Description

Developer of microbiome-based personalized biotherapeutics designed to improve patients' quality of life while reducing dependence on antibiotics. The company utilizes sequencing platforms and machine learning algorithms and leverages knowledge of molecular and functional interactions between the microbiome and the human body to generate proprietary databases for comparing and detecting an individual's microbiome to design personalized therapeutics, enabling people to balance the good bacteria in their gut and stay healthy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 370 Torbay Road
  • Suite Number E130
  • Saint John's, Newfoundland and Labrador A1A 3W8
  • Canada
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • 370 Torbay Road
  • Suite Number E130
  • Saint John's, Newfoundland and Labrador A1A 3W8
  • Canada

Nucliq Biologics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nucliq Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Grant 17-Jan-2024 $339K Completed Generating Revenue
9. Accelerator/Incubator 18-Oct-2023 Completed Generating Revenue
8. Accelerator/Incubator 11-Jul-2023 Completed Generating Revenue
7. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
6. Accelerator/Incubator Completed Generating Revenue
5. Grant 29-Dec-2020 Completed Generating Revenue
4. Accelerator/Incubator 01-Sep-2020 Completed Generating Revenue
3. Accelerator/Incubator 01-Aug-2020 Completed Generating Revenue
2. Grant 17-Jun-2020 $25K Completed Generating Revenue
1. Seed Round 01-May-2020 Completed Startup
To view Nucliq Biologics’s complete valuation and funding history, request access »

Nucliq Biologics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nucliq Biologics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Emergence Incubator Accelerator/Incubator
Nrth Toronto Accelerator/Incubator
Government of Newfoundland and Labrador Government
Bounce Health Innovation Accelerator/Incubator
Genesis Centre Accelerator/Incubator
You’re viewing 5 of 8 investors. Get the full list »

Nucliq Biologics FAQs

  • When was Nucliq Biologics founded?

    Nucliq Biologics was founded in 2019.

  • Where is Nucliq Biologics headquartered?

    Nucliq Biologics is headquartered in Saint John's, Canada.

  • What is the size of Nucliq Biologics?

    Nucliq Biologics has 8 total employees.

  • What industry is Nucliq Biologics in?

    Nucliq Biologics’s primary industry is Biotechnology.

  • Is Nucliq Biologics a private or public company?

    Nucliq Biologics is a Private company.

  • What is Nucliq Biologics’s current revenue?

    The current revenue for Nucliq Biologics is .

  • Who are Nucliq Biologics’s investors?

    Emergence Incubator, Nrth Toronto, Government of Newfoundland and Labrador, Bounce Health Innovation, and Genesis Centre are 5 of 8 investors who have invested in Nucliq Biologics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process